 Samuel Gubbels
Concepts (362)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cochlear Implants | 8 | 2023 | 96 | 3.100 |
Why?
| | Neuroma, Acoustic | 9 | 2024 | 55 | 2.960 |
Why?
| | Cochlear Implantation | 8 | 2023 | 83 | 2.660 |
Why?
| | Cochlea | 10 | 2024 | 73 | 2.570 |
Why?
| | Hearing Loss | 9 | 2025 | 249 | 2.280 |
Why?
| | Speech Perception | 6 | 2024 | 91 | 1.980 |
Why?
| | Hearing | 9 | 2025 | 133 | 1.630 |
Why?
| | Audiometry, Pure-Tone | 5 | 2024 | 33 | 1.410 |
Why?
| | Semicircular Canals | 4 | 2021 | 37 | 1.330 |
Why?
| | Ear, Inner | 6 | 2024 | 51 | 1.140 |
Why?
| | Nestin | 3 | 2024 | 19 | 1.140 |
Why?
| | Deafness | 5 | 2023 | 78 | 0.980 |
Why?
| | Otitis Media | 7 | 2022 | 182 | 0.980 |
Why?
| | Radiosurgery | 3 | 2019 | 399 | 0.940 |
Why?
| | Otitis Media with Effusion | 3 | 2014 | 20 | 0.860 |
Why?
| | Hair Cells, Auditory | 5 | 2024 | 45 | 0.820 |
Why?
| | Vestibule, Labyrinth | 2 | 2024 | 91 | 0.810 |
Why?
| | Nasopharyngeal Diseases | 2 | 2014 | 5 | 0.800 |
Why?
| | Gentamicins | 1 | 2023 | 50 | 0.760 |
Why?
| | Unnecessary Procedures | 2 | 2014 | 54 | 0.760 |
Why?
| | Labyrinth Diseases | 3 | 2020 | 8 | 0.700 |
Why?
| | Endoscopy | 3 | 2020 | 317 | 0.680 |
Why?
| | Human Embryonic Stem Cells | 1 | 2021 | 24 | 0.680 |
Why?
| | Hair Cells, Auditory, Inner | 1 | 2021 | 16 | 0.670 |
Why?
| | Pluripotent Stem Cells | 1 | 2021 | 82 | 0.640 |
Why?
| | Otolaryngologists | 1 | 2020 | 13 | 0.630 |
Why?
| | Ear Neoplasms | 2 | 2024 | 10 | 0.620 |
Why?
| | Temporal Bone | 6 | 2024 | 48 | 0.590 |
Why?
| | Paraganglioma | 1 | 2020 | 64 | 0.590 |
Why?
| | Skull Base Neoplasms | 1 | 2019 | 30 | 0.580 |
Why?
| | Tinnitus | 3 | 2018 | 69 | 0.570 |
Why?
| | Eustachian Tube | 1 | 2018 | 9 | 0.560 |
Why?
| | Meningioma | 1 | 2019 | 88 | 0.550 |
Why?
| | Meningeal Neoplasms | 1 | 2019 | 95 | 0.550 |
Why?
| | Vertigo | 3 | 2023 | 55 | 0.550 |
Why?
| | Hearing Loss, Sensorineural | 6 | 2022 | 73 | 0.550 |
Why?
| | Hearing Aids | 3 | 2025 | 98 | 0.550 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2018 | 78 | 0.530 |
Why?
| | Radiation Injuries | 1 | 2018 | 149 | 0.510 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3904 | 0.510 |
Why?
| | Physicians' Offices | 1 | 2016 | 18 | 0.490 |
Why?
| | Surgical Flaps | 2 | 2016 | 142 | 0.480 |
Why?
| | Humans | 64 | 2025 | 145474 | 0.470 |
Why?
| | Membrane Proteins | 2 | 2020 | 1164 | 0.470 |
Why?
| | Suture Anchors | 1 | 2016 | 35 | 0.460 |
Why?
| | Hearing Tests | 3 | 2025 | 53 | 0.460 |
Why?
| | Skin Transplantation | 1 | 2016 | 85 | 0.450 |
Why?
| | Sex Characteristics | 1 | 2021 | 782 | 0.450 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 561 | 0.440 |
Why?
| | Benign Paroxysmal Positional Vertigo | 3 | 2021 | 8 | 0.430 |
Why?
| | Device Removal | 1 | 2016 | 142 | 0.430 |
Why?
| | Cranial Fossa, Middle | 2 | 2020 | 19 | 0.420 |
Why?
| | Bacteriological Techniques | 1 | 2014 | 66 | 0.420 |
Why?
| | Blood | 1 | 2014 | 107 | 0.420 |
Why?
| | Cell Differentiation | 2 | 2021 | 2046 | 0.410 |
Why?
| | Hyperacusis | 1 | 2014 | 9 | 0.410 |
Why?
| | Cholesteatoma | 1 | 2014 | 10 | 0.410 |
Why?
| | Tomography, X-Ray Computed | 7 | 2016 | 2769 | 0.390 |
Why?
| | Jugular Veins | 1 | 2013 | 42 | 0.380 |
Why?
| | Glomus Jugulare Tumor | 1 | 2012 | 5 | 0.380 |
Why?
| | Carotid Body Tumor | 1 | 2012 | 5 | 0.370 |
Why?
| | Polyvinyls | 1 | 2012 | 19 | 0.370 |
Why?
| | Otologic Surgical Procedures | 5 | 2024 | 25 | 0.370 |
Why?
| | Influenza B virus | 1 | 2012 | 47 | 0.360 |
Why?
| | Carotid Artery, Internal | 1 | 2012 | 45 | 0.360 |
Why?
| | Cranial Nerve Diseases | 1 | 2012 | 44 | 0.360 |
Why?
| | Patient Selection | 1 | 2016 | 738 | 0.360 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2012 | 19 | 0.360 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 779 | 0.360 |
Why?
| | Bacteremia | 1 | 2014 | 222 | 0.360 |
Why?
| | Mutation | 2 | 2020 | 4075 | 0.350 |
Why?
| | Stapes Surgery | 2 | 2023 | 10 | 0.350 |
Why?
| | Melanoma | 1 | 2018 | 759 | 0.350 |
Why?
| | Denmark | 5 | 2016 | 51 | 0.340 |
Why?
| | Influenza A virus | 1 | 2012 | 119 | 0.340 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 591 | 0.330 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 159 | 0.330 |
Why?
| | Middle Aged | 20 | 2024 | 36215 | 0.330 |
Why?
| | Artifacts | 2 | 2023 | 143 | 0.320 |
Why?
| | Retrospective Studies | 15 | 2024 | 17291 | 0.320 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
| | Embolization, Therapeutic | 1 | 2012 | 242 | 0.310 |
Why?
| | Female | 26 | 2024 | 78844 | 0.300 |
Why?
| | Aging | 2 | 2021 | 1969 | 0.300 |
Why?
| | Laser Therapy | 2 | 2023 | 144 | 0.300 |
Why?
| | Male | 29 | 2024 | 72842 | 0.300 |
Why?
| | Transfection | 2 | 2009 | 926 | 0.300 |
Why?
| | Adult | 22 | 2025 | 40777 | 0.300 |
Why?
| | Genetic Therapy | 5 | 2020 | 316 | 0.290 |
Why?
| | Bacteria | 1 | 2014 | 765 | 0.290 |
Why?
| | Animals | 17 | 2024 | 38030 | 0.270 |
Why?
| | Mice | 11 | 2024 | 18329 | 0.270 |
Why?
| | Cerebrospinal Fluid Otorrhea | 1 | 2007 | 6 | 0.270 |
Why?
| | Encephalocele | 1 | 2007 | 12 | 0.270 |
Why?
| | Nasopharynx | 2 | 2022 | 72 | 0.270 |
Why?
| | Uterus | 1 | 2008 | 227 | 0.250 |
Why?
| | Urinary Tract Infections | 2 | 2022 | 210 | 0.250 |
Why?
| | Cross Infection | 2 | 2022 | 260 | 0.240 |
Why?
| | Tracheal Diseases | 1 | 2006 | 15 | 0.240 |
Why?
| | Influenza, Human | 1 | 2012 | 624 | 0.240 |
Why?
| | Bioprosthesis | 1 | 2006 | 39 | 0.240 |
Why?
| | Aged | 14 | 2024 | 26153 | 0.230 |
Why?
| | Intensive Care Units | 1 | 2012 | 924 | 0.230 |
Why?
| | Neurons | 1 | 2015 | 1649 | 0.230 |
Why?
| | Petrous Bone | 1 | 2024 | 8 | 0.220 |
Why?
| | Cholesteatoma, Middle Ear | 1 | 2024 | 4 | 0.220 |
Why?
| | Airway Obstruction | 1 | 2006 | 153 | 0.210 |
Why?
| | Treatment Outcome | 10 | 2024 | 11772 | 0.210 |
Why?
| | Trachea | 1 | 2006 | 258 | 0.210 |
Why?
| | Saccule and Utricle | 1 | 2024 | 13 | 0.200 |
Why?
| | Incidence | 5 | 2016 | 2923 | 0.200 |
Why?
| | Audiometry | 2 | 2014 | 35 | 0.200 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2003 | 17 | 0.200 |
Why?
| | Cadaver | 5 | 2023 | 311 | 0.190 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2003 | 47 | 0.190 |
Why?
| | Penicillins | 1 | 2023 | 62 | 0.190 |
Why?
| | Meniere Disease | 1 | 2023 | 36 | 0.180 |
Why?
| | Neurofibromatosis 2 | 1 | 2022 | 4 | 0.180 |
Why?
| | Synapses | 2 | 2021 | 439 | 0.180 |
Why?
| | Haemophilus Infections | 1 | 2022 | 45 | 0.170 |
Why?
| | Microsurgery | 2 | 2020 | 76 | 0.170 |
Why?
| | Otolithic Membrane | 1 | 2021 | 7 | 0.170 |
Why?
| | Stem Cell Transplantation | 2 | 2021 | 189 | 0.170 |
Why?
| | Labyrinthitis | 1 | 2021 | 3 | 0.170 |
Why?
| | Neurons, Efferent | 1 | 2021 | 9 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2023 | 114 | 0.170 |
Why?
| | Vestibular Nerve | 1 | 2021 | 18 | 0.170 |
Why?
| | Aged, 80 and over | 6 | 2016 | 8333 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2188 | 0.160 |
Why?
| | Intestinal Mucosa | 1 | 2006 | 675 | 0.160 |
Why?
| | Vestibular Diseases | 1 | 2021 | 57 | 0.160 |
Why?
| | Scoliosis | 1 | 2023 | 221 | 0.160 |
Why?
| | Noise | 1 | 2021 | 72 | 0.160 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 627 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2023 | 254 | 0.160 |
Why?
| | Ear, Middle | 4 | 2022 | 84 | 0.150 |
Why?
| | Magnets | 1 | 2019 | 21 | 0.150 |
Why?
| | Microbiota | 3 | 2022 | 730 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Mutation, Missense | 1 | 2020 | 335 | 0.140 |
Why?
| | Hearing Loss, Bilateral | 1 | 2018 | 13 | 0.140 |
Why?
| | Hearing Loss, Sudden | 1 | 2018 | 12 | 0.140 |
Why?
| | Surgical Equipment | 1 | 2017 | 8 | 0.130 |
Why?
| | Mucous Membrane | 1 | 2018 | 128 | 0.130 |
Why?
| | Neurotology | 1 | 2017 | 5 | 0.130 |
Why?
| | Hearing Loss, Noise-Induced | 1 | 2017 | 18 | 0.130 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2018 | 127 | 0.130 |
Why?
| | Hospitals | 3 | 2022 | 732 | 0.130 |
Why?
| | Green Fluorescent Proteins | 2 | 2016 | 407 | 0.130 |
Why?
| | Genetic Testing | 1 | 2020 | 480 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 618 | 0.120 |
Why?
| | Dissection | 1 | 2017 | 57 | 0.120 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5983 | 0.120 |
Why?
| | Patient Positioning | 1 | 2017 | 70 | 0.120 |
Why?
| | Regeneration | 1 | 2018 | 197 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 170 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 777 | 0.120 |
Why?
| | Hearing Loss, Unilateral | 1 | 2016 | 5 | 0.120 |
Why?
| | Infant | 7 | 2019 | 10077 | 0.120 |
Why?
| | Diagnosis, Differential | 5 | 2021 | 1508 | 0.120 |
Why?
| | Electrodes, Implanted | 1 | 2016 | 114 | 0.120 |
Why?
| | Age Factors | 3 | 2012 | 3342 | 0.120 |
Why?
| | Organogenesis | 1 | 2016 | 63 | 0.120 |
Why?
| | Automation | 1 | 2016 | 104 | 0.120 |
Why?
| | Scalp | 1 | 2016 | 38 | 0.120 |
Why?
| | Epidemiological Monitoring | 1 | 2016 | 69 | 0.110 |
Why?
| | Adolescent | 8 | 2023 | 22529 | 0.110 |
Why?
| | Plant Lectins | 1 | 2015 | 8 | 0.110 |
Why?
| | Ifosfamide | 1 | 2015 | 39 | 0.110 |
Why?
| | Child, Preschool | 7 | 2019 | 11853 | 0.110 |
Why?
| | Estrogen Antagonists | 1 | 2015 | 37 | 0.110 |
Why?
| | Durapatite | 2 | 2021 | 37 | 0.110 |
Why?
| | Child | 9 | 2023 | 22707 | 0.110 |
Why?
| | Ki-67 Antigen | 1 | 2015 | 117 | 0.110 |
Why?
| | Etoposide | 1 | 2015 | 168 | 0.110 |
Why?
| | Audiology | 1 | 2014 | 21 | 0.100 |
Why?
| | Tamoxifen | 1 | 2015 | 191 | 0.100 |
Why?
| | Quality of Life | 3 | 2023 | 3204 | 0.100 |
Why?
| | Pedigree | 3 | 2020 | 515 | 0.100 |
Why?
| | Luminescent Proteins | 1 | 2015 | 186 | 0.100 |
Why?
| | Educational Measurement | 1 | 2017 | 326 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2016 | 891 | 0.100 |
Why?
| | Methotrexate | 1 | 2015 | 233 | 0.100 |
Why?
| | Genetic Variation | 1 | 2018 | 972 | 0.100 |
Why?
| | Head Injuries, Closed | 2 | 2014 | 49 | 0.100 |
Why?
| | Eye Movement Measurements | 1 | 2013 | 14 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3413 | 0.100 |
Why?
| | Vestibular Evoked Myogenic Potentials | 1 | 2013 | 19 | 0.100 |
Why?
| | Young Adult | 6 | 2019 | 14218 | 0.090 |
Why?
| | Hearing Loss, Mixed Conductive-Sensorineural | 1 | 2012 | 4 | 0.090 |
Why?
| | Central Nervous System Cysts | 1 | 2012 | 13 | 0.090 |
Why?
| | Oral Surgical Procedures | 2 | 2011 | 4 | 0.090 |
Why?
| | Meat Products | 1 | 2012 | 9 | 0.090 |
Why?
| | Salmonella Food Poisoning | 1 | 2012 | 10 | 0.090 |
Why?
| | Disease Notification | 1 | 2012 | 16 | 0.090 |
Why?
| | Follow-Up Studies | 5 | 2010 | 5423 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1923 | 0.090 |
Why?
| | Food Contamination | 1 | 2012 | 33 | 0.090 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 401 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1767 | 0.090 |
Why?
| | Seasons | 1 | 2014 | 538 | 0.090 |
Why?
| | Laryngoscopy | 1 | 2013 | 119 | 0.090 |
Why?
| | Phenotype | 1 | 2020 | 3155 | 0.090 |
Why?
| | Labyrinth Supporting Cells | 1 | 2011 | 3 | 0.090 |
Why?
| | Disease Progression | 1 | 2019 | 2864 | 0.090 |
Why?
| | Biomedical Research | 1 | 2018 | 717 | 0.090 |
Why?
| | Organ of Corti | 1 | 2011 | 14 | 0.080 |
Why?
| | Radiography | 1 | 2014 | 852 | 0.080 |
Why?
| | Age Distribution | 1 | 2012 | 403 | 0.080 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2011 | 7 | 0.080 |
Why?
| | Viral Tropism | 1 | 2011 | 36 | 0.080 |
Why?
| | Sex Distribution | 1 | 2012 | 387 | 0.080 |
Why?
| | Foodborne Diseases | 1 | 2012 | 59 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2016 | 2121 | 0.080 |
Why?
| | Skull Base | 2 | 2021 | 55 | 0.080 |
Why?
| | Lasers | 2 | 2023 | 126 | 0.080 |
Why?
| | Ear Canal | 1 | 2011 | 14 | 0.080 |
Why?
| | Ganglion Cysts | 1 | 2011 | 10 | 0.080 |
Why?
| | Ear Diseases | 1 | 2011 | 20 | 0.080 |
Why?
| | Cranial Nerve Neoplasms | 1 | 2010 | 8 | 0.080 |
Why?
| | Sex Factors | 2 | 2014 | 2105 | 0.080 |
Why?
| | Zygoma | 1 | 2010 | 7 | 0.080 |
Why?
| | Neurosurgical Procedures | 1 | 2012 | 202 | 0.080 |
Why?
| | Dependovirus | 1 | 2011 | 78 | 0.080 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1997 | 0.080 |
Why?
| | Salmonella typhimurium | 1 | 2012 | 188 | 0.080 |
Why?
| | Adenoviridae | 1 | 2011 | 199 | 0.080 |
Why?
| | Magnetic Resonance Angiography | 1 | 2012 | 251 | 0.080 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2597 | 0.080 |
Why?
| | Abscess | 1 | 2010 | 77 | 0.080 |
Why?
| | Cost of Illness | 1 | 2012 | 324 | 0.080 |
Why?
| | Gene Transfer Techniques | 1 | 2011 | 187 | 0.080 |
Why?
| | Genetic Vectors | 1 | 2011 | 335 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 614 | 0.070 |
Why?
| | Maxilla | 1 | 2009 | 36 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 740 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2016 | 2507 | 0.070 |
Why?
| | Skull Fractures | 1 | 2009 | 36 | 0.070 |
Why?
| | Clinical Competence | 1 | 2017 | 1243 | 0.070 |
Why?
| | Middle Ear Ventilation | 1 | 2008 | 18 | 0.070 |
Why?
| | Comorbidity | 1 | 2014 | 1661 | 0.070 |
Why?
| | Disease Outbreaks | 1 | 2012 | 419 | 0.070 |
Why?
| | Electroporation | 1 | 2009 | 43 | 0.070 |
Why?
| | Electric Conductivity | 1 | 2008 | 85 | 0.070 |
Why?
| | Electroencephalography | 1 | 2012 | 561 | 0.070 |
Why?
| | Population Surveillance | 1 | 2012 | 484 | 0.070 |
Why?
| | Dyneins | 1 | 2008 | 34 | 0.070 |
Why?
| | Prospective Studies | 3 | 2012 | 8057 | 0.070 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 583 | 0.070 |
Why?
| | Swine | 2 | 2012 | 825 | 0.070 |
Why?
| | Myosins | 1 | 2008 | 132 | 0.070 |
Why?
| | Cleft Lip | 1 | 2008 | 73 | 0.070 |
Why?
| | Bone Cements | 1 | 2007 | 39 | 0.070 |
Why?
| | Chronic Disease | 1 | 2014 | 1808 | 0.070 |
Why?
| | Cleft Palate | 1 | 2008 | 91 | 0.060 |
Why?
| | Craniotomy | 1 | 2007 | 84 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2008 | 4560 | 0.060 |
Why?
| | Mechanotransduction, Cellular | 1 | 2008 | 121 | 0.060 |
Why?
| | Internship and Residency | 1 | 2017 | 1267 | 0.060 |
Why?
| | Tonsillar Neoplasms | 1 | 2005 | 10 | 0.060 |
Why?
| | Neck Dissection | 1 | 2005 | 17 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 286 | 0.060 |
Why?
| | Random Allocation | 1 | 2006 | 365 | 0.060 |
Why?
| | Neck | 1 | 2005 | 108 | 0.060 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2005 | 106 | 0.060 |
Why?
| | Prevalence | 1 | 2012 | 2865 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1963 | 0.050 |
Why?
| | Intestine, Small | 1 | 2006 | 167 | 0.050 |
Why?
| | Rabbits | 1 | 2006 | 652 | 0.050 |
Why?
| | Biomarkers | 1 | 2016 | 4295 | 0.050 |
Why?
| | Biopsy | 2 | 2011 | 1082 | 0.050 |
Why?
| | Neurilemmoma | 1 | 2024 | 25 | 0.050 |
Why?
| | Models, Animal | 1 | 2006 | 393 | 0.050 |
Why?
| | Safety | 1 | 2006 | 358 | 0.050 |
Why?
| | Hearing Disorders | 1 | 2003 | 10 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2007 | 429 | 0.050 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2003 | 33 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2012 | 3623 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2014 | 6447 | 0.050 |
Why?
| | Algorithms | 3 | 2017 | 1845 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2024 | 257 | 0.050 |
Why?
| | Eye Diseases | 1 | 2003 | 97 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2021 | 2970 | 0.040 |
Why?
| | Hydroxyapatites | 1 | 2021 | 16 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.040 |
Why?
| | Hospitalization | 1 | 2012 | 2460 | 0.040 |
Why?
| | Esthetics | 1 | 2021 | 50 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2021 | 2 | 0.040 |
Why?
| | Lithiasis | 1 | 2021 | 3 | 0.040 |
Why?
| | Recurrence | 1 | 2024 | 1138 | 0.040 |
Why?
| | Facial Nerve | 1 | 2021 | 39 | 0.040 |
Why?
| | Auditory Threshold | 2 | 2011 | 51 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2005 | 641 | 0.040 |
Why?
| | Scala Tympani | 1 | 2020 | 5 | 0.040 |
Why?
| | Nose | 1 | 2020 | 67 | 0.040 |
Why?
| | Infection Control | 1 | 2022 | 173 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 484 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 507 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2021 | 219 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 79 | 0.040 |
Why?
| | Finland | 1 | 2019 | 78 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2012 | 6066 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 246 | 0.040 |
Why?
| | Pregnancy | 2 | 2009 | 7202 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2018 | 33 | 0.030 |
Why?
| | Incus | 1 | 2017 | 6 | 0.030 |
Why?
| | Ear Ossicles | 1 | 2017 | 11 | 0.030 |
Why?
| | Diffusion of Innovation | 1 | 2018 | 96 | 0.030 |
Why?
| | Exome | 1 | 2018 | 227 | 0.030 |
Why?
| | Stapes | 1 | 2017 | 25 | 0.030 |
Why?
| | Iatrogenic Disease | 1 | 2017 | 74 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 442 | 0.030 |
Why?
| | Pressure | 1 | 2017 | 226 | 0.030 |
Why?
| | Forecasting | 1 | 2018 | 390 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 1111 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 428 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 741 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 825 | 0.030 |
Why?
| | Speech Intelligibility | 1 | 2014 | 4 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 946 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2018 | 381 | 0.030 |
Why?
| | Time | 1 | 2014 | 84 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2005 | 2214 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 1149 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2823 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2158 | 0.020 |
Why?
| | Bacteriophage Typing | 1 | 2012 | 1 | 0.020 |
Why?
| | Abattoirs | 1 | 2012 | 2 | 0.020 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2012 | 22 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2012 | 36 | 0.020 |
Why?
| | Cues | 1 | 2014 | 327 | 0.020 |
Why?
| | Microinjections | 1 | 2011 | 92 | 0.020 |
Why?
| | Transduction, Genetic | 1 | 2011 | 132 | 0.020 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2011 | 50 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2378 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2011 | 333 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1001 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2011 | 408 | 0.020 |
Why?
| | Functional Laterality | 1 | 2010 | 240 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2009 | 115 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 368 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1261 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 969 | 0.020 |
Why?
| | Probability | 1 | 2008 | 307 | 0.020 |
Why?
| | Gestational Age | 1 | 2011 | 987 | 0.020 |
Why?
| | Stem Cells | 1 | 2011 | 628 | 0.020 |
Why?
| | RNA Interference | 1 | 2007 | 475 | 0.010 |
Why?
| | Signal Transduction | 1 | 2019 | 5216 | 0.010 |
Why?
| | Fluorouracil | 1 | 2005 | 231 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 2005 | 331 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2005 | 423 | 0.010 |
Why?
| | Models, Theoretical | 1 | 2007 | 558 | 0.010 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 910 | 0.010 |
Why?
| | Cisplatin | 1 | 2005 | 345 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1044 | 0.010 |
Why?
| | United States | 1 | 2019 | 16098 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 3747 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 7123 | 0.010 |
Why?
|
|
Gubbels's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|